Herb Profile

Notoginseng

Panax notoginseng

Notoginseng (Panax notoginseng) carries a Grade C rating — limited evidence.

Last reviewed: June 6, 2026•3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution — May affect platelet aggregation and bleeding risk; use caution with anticoagulants/antiplatelets, before surgery, and during pregnancy unless supervised. Details

Evidence: Limited Evidence
Typical onset: Varies by prep
Safety rating: Moderate caution
Best for: Cardiovascular, Anti Inflammatory, Metabolic, Inflammatory signaling
Avoid / review if: Pregnancy, Anticoagulant/Antiplatelet Use Without Clinician Review, Upcoming Surgery

Generated profile category visual

At a glance

From this profile's structured data

Evidence: Grade C
Safety: May affect platelet aggregation and bleeding risk; use caution with anticoagulants/antiplatelets, before surgery, and during pregnancy unless supervised.
Profile context: cardiovascular, anti-inflammatory, metabolic

Next stepsWhere to go next — guides & comparisons

If you want to browse more herbs → All herbs

Safety

Safety & Cautions

May affect platelet aggregation and bleeding risk; use caution with anticoagulants/antiplatelets, before surgery, and during pregnancy unless supervised.

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

Pregnancy
Anticoagulant/Antiplatelet Use Without Clinician Review
Upcoming Surgery
May Interact With Anticoagulants
Antiplatelets
Antihypertensives
And Antidiabetics.

Safety classifications

Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.

Full safety note

May affect platelet aggregation and bleeding risk; use caution with anticoagulants/antiplatelets, before surgery, and during pregnancy unless supervised.

Safety labels

Anticoagulant Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Bleeding / anticoagulant riskCertainty: Theoretical

Data provenance recorded for 147 of 147 pairings in this mechanism group.

+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Moderate Caution

191 flagged pairings

Blood-sugar lowering · Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Blood-sugar loweringCertainty: Theoretical

Data provenance recorded for 110 of 110 pairings in this mechanism group.

+98 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Blood-pressure effectsCertainty: Theoretical

Data provenance recorded for 81 of 81 pairings in this mechanism group.

+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Metabolic Regulation · Vascular Function Support

Research maturity: Emerging research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — May affect platelet aggregation and bleeding risk; use caution with anticoagulants/antiplatelets, before surgery, and during pregnancy unless supervised.

This profile cites 3 human studies.

Study design details

Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Meta-analysis
Risk of Bias: Low
Consistency: Not assessed

Strongest recorded design is a meta-analysis, drawn from 3 recorded studies, 2 in people.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (5)2 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 2 human evidence sources; 0 are human trials.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
A 2025 network meta-analysis of Panax notoginseng saponin interventions for ischemic stroke reported favorable signals across several outcomes, but much of the evidence comes from Chinese trials with variable quality and adjunctive regimens. Background	Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.	—	—	—	—	—	A 2025 network meta-analysis of Panax notoginseng saponin interventions for ischemic stroke reported favorable signals across several outcomes, but much of the evidence comes from Chinese trials with variable quality and adjunctive regimens.	PubMed →
PMID 38898926 Background	Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.	—	—	—	—	—	A 2024 systematic review/meta-analysis of 20 trials (1,856 participants) reported short-term NIHSS and activities-of-daily-living improvements when PNS injections were added after thrombolysis, with no clear adverse-event increase. Crucially, none of the trials reported mortality or disability and certainty ranged from moderate to very low.	PubMed →
Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy Liu H et al. · Pharmacol Res · 2020 Background	Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review.	—	—	—	—	—	—	PubMed →
Panax notoginseng: derived exosome-like nanoparticles attenuate ischemia reperfusion injury via altering microglia polarization Li S et al. · J Nanobiotechnology · 2023 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis Han J et al. · J Diabetes Res · 2022 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →

Dosing & Timing

No standardized dose: Preparation specific; use standardized product label for Root powder and require source backed dosage review before therapeutic claims.

How Notoginseng works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Notoginseng Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Mechanisms & biological pathways (preclinical)

Inflammatory Signaling Modulation
Metabolic Regulation
Vascular Function Support

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Open the full activity atlasCompare effects, evidence, and safety

Guides that use Notoginseng

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Notoginseng

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Continue comparing

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Notoginseng research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs library Safety checker →